NEW YORK - Element Biosciences said on Tuesday that its upcoming Aviti sequencing platform will be compatible with Roche's Kapa library preparation and target enrichment kits. The company also announced new partnerships with Agilent Technologies, New England Biolabs, Qiagen, and Watchmaker Genomics to integrate the Aviti system with those firms' existing NGS products.
"Demonstrating compatibility of our Kapa chemistry with Element's sequencing platform offers our customers more flexibility across applications and sequencing platforms to address the growing need for high-performing NGS solutions," said Cindy Perettie, head of molecular labs at Roche, in a statement.
Under the partnership with Agilent, company researchers have validated Agilent's SureSelect target enrichment panels for use with the Aviti system.
Teaming up with Qiagen, Element will validate Qiagen's QiaSeq NGS library prep and target enrichment products on Aviti.
Element's collaborations with New England Biolabs and Watchmaker Genomics will enable Aviti customers to use these companies' library preparation technologies, including NEB's NEBNext Ultra II portfolio and Watchmaker's DNA and RNA Library Prep Kits.
Financial and other terms of the deals were not disclosed.
Earlier this month, San Diego-based Element Biosciences acquired Loop Genomics, which sells sample prep kits and sequencing services that provide synthetic long reads using short-read sequencing.
Element said it plans to release more details about its new sequencing platform on March 14.